MA-SKILLSOFT
9.5.2017 15:54:12 CEST | Business Wire | Press release
Skillsoft , the global leader in eLearning and Talent Management, today announced it has appointed Larry Neal as Chief Executive Officer of the group. Bill Donoghue, current CEO, becomes Executive Chairman.
Most recently, Larry has led businesses for S&P Global, formerly McGraw-Hill Financial. As President of S&P Platts, he drove outstanding growth, nearly tripling revenues in seven years. Platts has customers in 170 countries, 60% of revenues outside of North America, and over 1,000 staff across 15 global locations. Prior to Platts, he led significant performance improvements at both the S&P Equity Research and S&P Index Services businesses.
Earlier in his career, Larry led several product, sales and marketing organizations and has extensive sales leadership experience. He started his career at General Electric and IBM, then moving in to sales and business leadership positions at technology-enabled content companies Advent Software, ADP and McGraw-Hill.
“Larry is an outstanding and experienced executive, having repeatedly delivered exceptional P&L performance for five companies. He has a reputation for bringing a unique blend of strategic insight with operational excellence and a relentless customer focus,” said Bill Donoghue, Executive Chairman of the Skillsoft Group. “I am thrilled Larry is joining us and confident he will make an excellent long-term CEO.”
Mr. Neal said: “I am delighted to be joining Skillsoft following the transformation of the group to a digital technology company. It is a world leader in online learning and talent management, with a huge and diverse portfolio of great clients, and committed, dedicated teams across the world. I am looking forward to working with the team through the next phase of the company’s development.”
Frank van den Bosch, Partner at Charterhouse Capital Partners, owners of Skillsoft, said: “Bill Donoghue stepped into the CEO role to lead the company through a huge transformation over the past 15 months, which has now been successfully completed. That transformation of Skillsoft into a digital technology company prepared the ground for a new long-term CEO and we are excited Larry is joining us. Larry brings a track record of growth experience, and is an exceptional operator and leader, whilst Bill will provide continuity and strategic guidance to the team as Executive Chairman.”
About Skillsoft
Skillsoft is the global leader in eLearning,
providing the most engaging learner experience and high-quality content.
We are trusted by the world's leading organizations, including 65
percent of the Fortune 500. Our mission is to build beautiful technology
and engaging content that drives business impact for today’s modern
enterprise. Our 150,000+ multi-modal courses, videos, books and
micro-learning modules are accessed more than 130 million times every
month, in 160 countries and 29 languages. With 100% secure cloud access,
from any device, whenever, wherever. www.skillsoft.com
About SumTotal Systems
SumTotal Systems, LLC, a Skillsoft
Company, is the world’s only unified Human Capital Management Solution.
SumTotal’s award-winning Talent Management Suite enables companies to
attract, know, mobilize, develop, progress and reward their workforce.
SumTotal is continuously innovating to best meet the market challenges
of attracting, retaining, developing and engaging the multi-generational
workforce. The Talent Expansion Suite includes three key components
–Talent, Learn and Work. www.sumtotalsystems.com
About Charterhouse Capital Partners
Charterhouse is one of
the longest established private equity firms operating in Europe. The
firm invests in companies headquartered in Western Europe and works
closely with incumbent management teams, backing them and providing
active support to drive growth. Charterhouse pursues a highly selective
investment approach, partnering with a small number of high-quality
companies. Transaction values range from €250mn to €2bn. Charterhouse is
based in London and has a deep bench of experienced investment
professionals. Since inception Charterhouse has completed over 140
transactions worth an aggregate value of over €50bn. www.charterhouse.co.uk
View source version on businesswire.com: http://www.businesswire.com/news/home/20170509006046/en/
Contact:
Skillsoft
Tara O’Sullivan, +353871771529
Chief Creative Officer
tara.osullivan@skillsoft.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press release
Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release
Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release
A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release
New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release
Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom